Prestige Consumer Healthcare
PBH
#4293
Rank
NZ$4.41 B
Marketcap
NZ$91.85
Share price
-9.02%
Change (1 day)
-38.22%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$6.53

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.67. In 2024 the company made an earnings per share (EPS) of NZ$7.53 an increase over its 2023 EPS that were of NZ-$2.82.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.53-13.19%
2024NZ$7.53-367.08%
2023NZ-$2.82-138.33%
2022NZ$7.3511.7%
2021NZ$6.5813.6%
2020NZ$5.79-651.67%
2019NZ-$1.05-148.78%
2018NZ$2.15-83.29%
2017NZ$12.88437.23%
2016NZ$2.40-34.13%
2015NZ$3.6452.94%
2014NZ$2.38-8.11%
2013NZ$2.59
2011NZ$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.49 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.09 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.60 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.38-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.56-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.76 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$2.47-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.59-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$51.84-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.14-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel